Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">LymphoStat-B: Phase II completed enrollment</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

HGSI completed enrollment of 283 patients in a double-blind, placebo-controlled Phase II trial. ......

autoimmune

Ophthalmic

LymphoStat-B: Phase II completed enrollment

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

East-West Healthcare Reception

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

BioCentury Grand Rounds Inquiry

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home